Latest News and Press Releases

Dresden, Germany, and Lexington, MA, May 8, 2025 – Seamless Therapeutics, today announced the appointment of Alvin Shih, M.D., M.B.A., as an Independent Director to its Board. Dr. Shih is an...

Avance Clinical, the award-winning, global CRO for biotechs, is proud to announce its sponsorship of the Citeline Awards 2025 tomorrow in Boston.

Additional investors include global investment firm Viking Global Investors, charity foundation CureEB, the Epidermolysis Bullosa Medical Research Foundation (EBMRF), and Stanford University. The...

BOSTON, MA, April 10, 2025 (GLOBE NEWSWIRE) -- Odylia Therapeutics (Odylia) a nonprofit biotechnology company dedicated to expediting drug development for rare diseases, hosted a Rare Disease Day...

Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites

Phase III study showed sustained proteinuria reduction at one year with favorable safety1Fabhalta is the only oral alternative complement pathway inhibitor thought to target the underlying cause...

Global Reach for US Biotechs: Avance Clinical Secures MOUs with Four Premier Taiwanese Trial Sites

If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney disease with no currently approved treatments2-5 ...

Simbec-Orion and Avance Clinical are thrilled to announce the signing of a Memorandum of Understanding (MOU).

Washington, D.C., Feb. 01, 2025 (GLOBE NEWSWIRE) -- As rural healthcare access shrinks across the United States and remains limited worldwide, Global Liver Institute (GLI) is shining a spotlight on...